Variability in total serum IgE over 1 year in severe asthmatics
Abstract Background Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgEtot) in asthmatics remains poorly documented. Methods In this prospective study, sIgEtot levels...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2019-03-01
|
| Sarja: | Allergy, Asthma & Clinical Immunology |
| Aiheet: | |
| Linkit: | http://link.springer.com/article/10.1186/s13223-019-0331-8 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|